Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Food-Effect of SYH2056 Tablets in Healthy Subjects

NCT07771777 is registered in ClinicalTrials.gov with InnovStone Therapeutics Limited as lead sponsor.

NCT NCT07771777
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07771777 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Food-Effect of SYH2056 Tablets in Healthy Subjects
Lead sponsor
InnovStone Therapeutics Limited
Phase
Phase 1
Overall status
Not yet recruiting
Start date
August 30, 2026
Completion date
March 30, 2027
Enrollment
72 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

healthy participants